Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 9, 2012, Pages 1520-1527

  Adams, Leon A ^a,b,c   Marsh, Julie A ^d   Ayonrinde, Oyekoya T ^a,e,f,g   Olynyk, John K ^a,e,f,g   Ang, Wei Q ^d   Beilin, Lawrence J ^a   Mori, Trevor ^a   Palmer, Lyle J ^h   Oddy, Wendy W ^c   Lye, Steven J ⁱ   Pennell, Craig E ^c,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e FREMANTLE HOSPITAL   (Australia)

^f CURTIN UNIVERSITY   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

ⁱ MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Adolescents; Non alcoholic fatty liver disease; Raine cohort

Indexed keywords

ABHD5 PROTEIN; ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN B100; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REGULATOR PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DNA EXTRACTION; ECHOGRAPHY; FATTY LIVER; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; SKINFOLD THICKNESS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WILD TYPE;

EID: 84865369139     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07120.x     Document Type: Article

References (47)

1. Struben VM, Hespenheide EE, Caldwell SH. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am. J. Med. 2000; 108: 9-13.
2. Guerrero R, Vega GL, Grundy SM, Browning JD. Ethnic differences in hepatic steatosis: an insulin resistance paradox? Hepatology 2009; 49: 791-801.
3. Speliotes EK. Genetics of common obesity and nonalcoholic fatty liver disease. Gastroenterology 2009; 136: 1492-5.
4. Wagenknecht LE, Scherzinger AL, Stamm ER etal. Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort. Obesity (Silver Spring) 2009; 17: 1240-6.
5. Schwimmer JB, Celedon MA, Lavine JE etal. Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009; 136: 1585-92.
6. Romeo S, Kozlitina J, Xing C etal. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 2008; 40: 1461-5.
7. Tian C, Stokowski RP, Kershenobich D, Ballinger DG, Hinds DA. Variant in PNPLA3 is associated with alcoholic liver disease. Nat. Genet. 2010; 42: 21-3.
8. Speliotes EK, Butler JL, Palmer CD, Voight BF, Hirschhorn JN. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 2010; 52: 904-12.
9. Hairston KG, Scherzinger A, Foy C etal. Five-year change in visceral adipose tissue quantity in a minority cohort: the Insulin Resistance Atherosclerosis Study (IRAS) family study. Diabetes Care 2009; 32: 1553-5.
10. He S, McPhaul C, Li JZ etal. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J. Biol. Chem. 2010; 285: 6706-15.
11. Fujita K, Nozaki Y, Wada K etal. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology 2009; 50: 772-80.
12. Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 2008; 134: 424-31.
13. Watts GF, Riches FM, Humphries SE, Talmud PJ, van Bockxmeer FM. Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity. J. Lipid Res. 2000; 41: 481-8.
14. Koutsari C, Lazaridis KN. Emerging genes associated with the progression of nonalcoholic fatty liver disease. Hepatology 2010; 52: 807-10.
15. Schweiger M, Lass A, Zimmermann R, Eichmann TO, Zechner R. Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. Am. J. Physiol. Endocrinol. Metab. 2009; 297: E289-96.
16. Zechner R, Kienesberger PC, Haemmerle G, Zimmermann R, Lass A. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J. Lipid Res. 2009; 50: 3-21.
17. Haemmerle G, Lass A, Zimmermann R etal. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312: 734-7.
18. Huang RC, de Klerk N, Mori TA etal. Differential relationships between anthropometry measures and cardiovascular risk factors in boys and girls. Int. J. Pediatr. Obes. 2011; 6: e271-82.
19. Robinson M, Oddy WH, McLean NJ etal. Low-moderate prenatal alcohol exposure and risk to child behavioural development: a prospective cohort study. BJOG 2010; 117: 1139-50.
20. Purcell S, Neale B, Todd-Brown K etal. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007; 81: 559-75.
21. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-3.
22. Hamaguchi M, Kojima T, Itoh Y etal. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am. J. Gastroenterol. 2007; 102: 2708-15.
23. Ayonrinde OT, Olynyk JK, Beilin LJ etal. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 2011; 53: 800-9.
24. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
25. Anagnostopoulou KK, Kolovou GD, Kostakou PM etal. Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia. Lipids Health Dis. 2009; 8: 24.
26. Bernard S, Touzet S, Personne I etal. Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes. Diabetologia 2000; 43: 995-9.
27. Chen S, Li Y, Li S, A Val YC. 227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio. J. Gastroenterol. Hepatol. 2008; 23: 1415-18.
28. Lass A, Zimmermann R, Haemmerle G etal. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab. 2006; 3: 309-19.
29. Namikawa C, Shu-Ping Z, Vyselaar JR etal. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J. Hepatol. 2004; 40: 781-6.
30. Ng TW, Ooi EM, Watts GF, Chan DC, Barrett PH. Genetic determinants of apolipoprotein B-100 kinetics. Curr. Opin. Lipidol. 2010; 21: 141-7.
31. Oliveira CP, Stefano JT, Cavaleiro AM etal. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 2010; 25: 357-61.
32. Bickel R. Multilevel Analysis for Applied Research: It's Just Regression! New York: The Guilford Press, 2007.
33. Team RDC. R: A Language and Environment for Statistical Computing. 2009.
34. Database NS. NCBI SNP Database. 2011. Available at URL: http://www.ncbi.nlm.nih.gov.
35. Oliveira HC, Chouinard RA, Agellon LB etal. Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5'-distal sequences. Cis-acting sequences mapped in transgenic mice. J. Biol. Chem. 1996; 271: 31831-8.
36. Xiao C, Watanabe T, Zhang Y etal. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia. Circ. Res. 2008; 103: 159-66.
37. Rashid S, Watanabe T, Sakaue T, Lewis GF. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. Clin. Biochem. 2003; 36: 421-9.
38. Blake WL, Ulrich RG, Marotti KR, Melchior GW. The development of fatty liver is accelerated in transgenic mice expressing cynomolgus monkey cholesteryl ester transfer protein. Biochem. Biophys. Res. Commun. 1994; 205: 1257-63.
39. Salerno AG, Patricio PR, Berti JA, Oliveira HC. Cholesteryl ester transfer protein (CETP) increases postprandial triglyceridaemia and delays triacylglycerol plasma clearance in transgenic mice. Biochem. J. 2009; 419: 629-34.
40. Thompson JF, Wood LS, Pickering EH, Dechairo B, Hyde CL. High-density genotyping and functional SNP localization in the CETP gene. J. Lipid Res. 2007; 48: 434-43.
41. Frisdal E, Klerkx AH, Le Goff W etal. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. Hum. Mol. Genet. 2005; 14: 2607-18.
42. Silliman K, Tall AR, Kretchmer N, Forte TM. Unusual high-density lipoprotein subclass distribution during late pregnancy. Metabolism 1993; 42: 1592-9.
43. Vadlamudi S, MacLean P, Green T etal. Role of female sex steroids in regulating cholesteryl ester transfer protein in transgenic mice. Metabolism 1998; 47: 1048-51.
44. Gambino R, Cassader M, Pagano G, Durazzo M, Musso G. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? Hepatology 2007; 45: 1097-107.
45. Kotronen A, Yki-Jarvinen H, Aminoff A etal. Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. Eur. J. Endocrinol. 2009; 160: 593-602.
46. Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011; 53: 1883-94.
47. Huang Y, Cohen JC, Hobbs HH. Expression and characterization of a PNPLA3 isoform (I148M) associated with nonalcoholic fatty liver disease. J. Biol. Chem. 2011; 286: 37085-93.